Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight ...

Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down following a plunge in the company's share price ...

For decades, the snack and beverage category has been dominated by companies that specialize in making delicious foods. Many ...

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

BENGALURU (Reuters) -U.S.-based Waters Corp, which makes medical equipment used in clinical testing, has seen a spurt in ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

Novo Nordisk looks to harness Septerna’s broader GPCR drug pathways, which include GLP-1, for obesity and diabetes treatments ...

Many play into fads with scant evidence to back up enthusiasts’ claims, medical experts say. Some influencers encourage their ...

Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...

A DAILY weight loss pill is a safer alternative to gastric bypass surgery, makers say. The tablet does the same job by making people feel full for longer. Its developers say the treatment is a ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will ...